Renaissance Capital logo

Invizyne Technologies Filed Terms, Nasdaq: IZTC

Developing a biomanufacturing platform for a diverse range of chemicals.

Industry: Materials

Latest Trade: ()

First Day Return:

Return from IPO:

Industry: Materials

Invizyne is redefining biomanufacturing by leveraging cell-free multi-step enzyme-based systems to efficiently transform natural or renewable resources into highly sought after chemicals. We believe that our biomanufacturing platform, known as SimplePath™, will be a significant alternative to the current methods of chemical compound production, which are generally chemical synthesis, natural extraction, and synthetic biology. Our objective with SimplePath™ is to enable the efficient production of a diverse range of chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. We believe that SimplePath™ not only can maximize the value of these resources but also will contribute to the development of novel chemical compounds that should open new markets and business opportunities. Our SimplePath™ platform consists of a series of modular cascading enzyme based biomanufacturing systems that leverage natural processes to perform complex chemical conversions, which systems may be coupled together or operate independently. Each system is comprised of several key parts (i.e. substrate(s), enzymes, cofactors, defined operating conditions, selected purification processes, and other system specific elements) that act together to produce one or more intended products.
more less
IPO Data
IPO File Date 02/09/2024
Offer Price
Price Range $8.00 - $8.00
Offer Shares (mm) 1.9
Deal Size ($mm) $15
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date
Offer Price
Price Range $8.00 - $8.00
Offer Shares (mm) 1.9
Deal Size ($mm) $15
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
MDB Capital Group
Company Data
Headquarters Monrovia, CA, United States
Founded 2019
Employees at IPO 29
Website www.invizyne.com

Invizyne Technologies (IZTC) Performance